Study of Novel Treatment Combinations in Patients With Lung Cancer

Clinical trial NCT05633667 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05633667
Sponsor: Gilead Sciences
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Advanced or Metastatic Non-Small-Cell Lung Cancer Resectable Non-Small-Cell Lung Cancer

Start date: 2023-03-16
Primary completion: 2029-09-01
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.